1.Mechanism study on the improvement of lung injury in mice with in-fluenza A virus pneumonia by Shufeng Jiedu capsules based on regu-lating intestinal microflora
Yikun WU ; Hongmin GUO ; Yan LI ; Weige MU ; Shuyun HUANG ; Jiuling ZHU ; Zhu YANG ; Shuzhi ZHONG
Chinese Journal of Clinical Pharmacology and Therapeutics 2025;30(10):1351-1360
AIM:To study the improvement effect and possible mechanism of Shufeng Jiedu capsules(SFJDC)on viral pneumonia.METHODS:Forty-eight BALB/c mice were used to establish a viral pneumo-nia model by intranasal administration of influenza A virus H1N1.They were randomly divided into 4 groups,with twelve mice in each group.Except for the Model group,the treatment group was given oseltamivir(OSTW),low and high dose groups of Shufeng Jiedu capsules(SFJDC-L,SFJD-H)by gavage,take another 12 mice as the normal group,continu-ously administered for 7 days.The physical signs of each group of mice were observed during the ad-ministration process,and the daily body weight change rate and disease activity index was calculat-ed;After administration,lung,intestinal tissue,and intestinal contents were taken,and the pathological changes in mouse lung tissue were detected using hematoxylin eosin(HE)staining method,Alisin blue staining was used to detect goblet cells in the intes-tinal wall;RT-qPCR method for detecting viral load influenza(infA)and the expression of tumor necro-sis factor-a(TNF-α)and interleukin-6(IL-6)mRNA in mouse lung tissue;Detection of mouse gut mi-crobiota using 16S rRNA high-throughput sequenc-ing;ELISA method for detecting lipopolysaccharide(LPS),TNF-α and IL-6 level in mouse serum;The ex-pression of cyclic GMP AMP synthase(cGAS),inter-feron gene stimulating protein(STING),phospho-STING(p-STING),nuclear factor-κB(NF-κB)phos-pho-nuclear factor-κB(p-NF-κB)in lung tissue and ZO-1,Occludin in small small intestine was detected by Western Blotting.RESULTS:Compared with the model group,the lung index and viral load of mice in the Shufeng Jiedu capsules group were signifi-cantly reduced(P<0.01);significant reduction in lung tissue inflammation accompanied by TNF-α;The expression level of IL-6 mRNA decreased(P<0.01);The abundance of Firmicutes and Lachnospi-raceae in the intestine significantly increased(P<0.01),while the abundance of Bacteroidetes and Bacteroidaceae communities significantly de-creased(P<0.05 or 0.01);The number of goblet cells in the small intestine epithelium significantly increased(P<0.01);the levels of serum LPS and TNF-α,IL-6 were significantly reduced(P<0.01);The protein expression level of cGAS,p-STING,p-NF-κB significantly decreased in lung tissue(P<0.05 or 0.01),ZO-1,Occludin significantly decreased in small intestine(P<0.05).CONCLUSION:Shufeng Jie-du capsules reduces the inflammatory response of mice lung tissue,and its mechanism may be relat-ed to its regulation of intestinal flora,protection of intestinal mucosal barrier,and reduction the activa-tion of cGAS/STING/NF-κB signaling pathway ac-tived by LPS leakaging from the intestine.
2.Mechanism study on the improvement of lung injury in mice with in-fluenza A virus pneumonia by Shufeng Jiedu capsules based on regu-lating intestinal microflora
Yikun WU ; Hongmin GUO ; Yan LI ; Weige MU ; Shuyun HUANG ; Jiuling ZHU ; Zhu YANG ; Shuzhi ZHONG
Chinese Journal of Clinical Pharmacology and Therapeutics 2025;30(10):1351-1360
AIM:To study the improvement effect and possible mechanism of Shufeng Jiedu capsules(SFJDC)on viral pneumonia.METHODS:Forty-eight BALB/c mice were used to establish a viral pneumo-nia model by intranasal administration of influenza A virus H1N1.They were randomly divided into 4 groups,with twelve mice in each group.Except for the Model group,the treatment group was given oseltamivir(OSTW),low and high dose groups of Shufeng Jiedu capsules(SFJDC-L,SFJD-H)by gavage,take another 12 mice as the normal group,continu-ously administered for 7 days.The physical signs of each group of mice were observed during the ad-ministration process,and the daily body weight change rate and disease activity index was calculat-ed;After administration,lung,intestinal tissue,and intestinal contents were taken,and the pathological changes in mouse lung tissue were detected using hematoxylin eosin(HE)staining method,Alisin blue staining was used to detect goblet cells in the intes-tinal wall;RT-qPCR method for detecting viral load influenza(infA)and the expression of tumor necro-sis factor-a(TNF-α)and interleukin-6(IL-6)mRNA in mouse lung tissue;Detection of mouse gut mi-crobiota using 16S rRNA high-throughput sequenc-ing;ELISA method for detecting lipopolysaccharide(LPS),TNF-α and IL-6 level in mouse serum;The ex-pression of cyclic GMP AMP synthase(cGAS),inter-feron gene stimulating protein(STING),phospho-STING(p-STING),nuclear factor-κB(NF-κB)phos-pho-nuclear factor-κB(p-NF-κB)in lung tissue and ZO-1,Occludin in small small intestine was detected by Western Blotting.RESULTS:Compared with the model group,the lung index and viral load of mice in the Shufeng Jiedu capsules group were signifi-cantly reduced(P<0.01);significant reduction in lung tissue inflammation accompanied by TNF-α;The expression level of IL-6 mRNA decreased(P<0.01);The abundance of Firmicutes and Lachnospi-raceae in the intestine significantly increased(P<0.01),while the abundance of Bacteroidetes and Bacteroidaceae communities significantly de-creased(P<0.05 or 0.01);The number of goblet cells in the small intestine epithelium significantly increased(P<0.01);the levels of serum LPS and TNF-α,IL-6 were significantly reduced(P<0.01);The protein expression level of cGAS,p-STING,p-NF-κB significantly decreased in lung tissue(P<0.05 or 0.01),ZO-1,Occludin significantly decreased in small intestine(P<0.05).CONCLUSION:Shufeng Jie-du capsules reduces the inflammatory response of mice lung tissue,and its mechanism may be relat-ed to its regulation of intestinal flora,protection of intestinal mucosal barrier,and reduction the activa-tion of cGAS/STING/NF-κB signaling pathway ac-tived by LPS leakaging from the intestine.
3.Challenges and countermeasures of thoracic surgery in the epidemic of novel coronavirus pneumonia
XIE Dong ; WANG Sihua ; JIANG Gening ; LIAO Yongde ; ZHU Yuming ; ZHANG Lei ; XU Zhifei ; CHEN Keneng ; FANG Wentao ; GE Di ; TAN Lijie ; CHEN Xiaofeng ; LI Hecheng ; WU Chuangyan ; TONG Song ; LIU Zheng ; DING Xiangchao ; CHEN Jiuling ; CHENG Chao ; WANG Haifeng ; CHEN Chang
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2020;27(04):359-363
Since December 2019, a novel coronavirus (2019-nCoV, SARS-CoV-2) pneumonia (COVID-19) outbreak has occurred in Wuhan, Hubei Province, and the epidemic situation has continued to spread. Such cases have also been found in other parts of the country. The spread of the novel coronavirus pneumonia epidemic has brought great challenges to the clinical practice of thoracic surgery. Outpatient clinics need to strengthen the differential diagnosis of ground glass opacity and pulmonary plaque shadows. During the epidemic, surgical indications are strictly controlled, and selective surgery is postponed. Patients planning to undergo a limited period of surgery should be quarantined for 2 weeks and have a nucleic acid test when necessary before surgery. For patients who are planning to undergo emergency surgery, nucleic acid testing should be carried out before surgery, and three-level protection should be performed during surgery. Patients who are planning to undergo emergency surgery in the epidemic area should be confirmed with or without novel coronavirus pneumonia before operation, and perform nucleic acid test if necessary. Surgical disinfection and isolation measures should be strictly carried out. Among postoperative patients, cases with new coronavirus infection were actively investigated. For the rescue of patients with novel coronavirus infection, attention needs to be paid to prevention and treatment and related complications, including mechanical ventilation-related pneumothorax or mediastinal emphysema, and injury after tracheal intubation.
4.Prediction of microvascular invasion in hepatocellular carcinoma patients by preoperative neutrophil-lymphocyte ratio and cancer-related factors
Yanlong YU ; Zhonghua LIU ; Ying SHI ; Qiang LI ; Jiuling SONG ; Ran ZHANG ; He LIU ; Jinming CHEN
Chinese Journal of Hepatobiliary Surgery 2019;25(2):120-123
Objective To predict the presence of MVI,the general clinicopathological of HCC patients' data of the preoperative neutrophil-lymphocyte ratio (NLR),platelet-lymphocyte ratio (PLR),altplatelet ratio (APRI) were evaluated.Methods 143 cases of HCC patients who underwent radical resection and ≤ 5 cm of tumor diameter in Chifeng Clinical Medical School of Inner Mongolia Medical University from January 2011 to December 2014 were analysed retrospectively and followed up.The relationship between NLR,PLR,APRI and other clinical parameters was evaluated.Results According to ROC Curve,the NLR truncation value was 2.00,PLR to 115.00,APRI 1.6.The single factor analysis of x2 test showed that NLR (x2=6.419;P<0.05),APRI (x2=3.975;P<0.05),AFP (x2=33.37;P<0.05),Degree of differentiation (x2 =9.839;P<0.05) were significant differences between MVI positive (MVI+) and negative (MVI-) groups,and the difference was statistically significant;Logistic regression multifactor analysis showed that NLR (OR 2.678;95% CI 1.033~6.944;P<0.05) and AFP (OR 1.724;95%CI 1.023~2.905;P<0.05) are independent predictors of MVI.Conclusion Preoperative NLR and AFP are convenient,economical and reliable hematological indices for predicting the presence of MVI in HCC patients.
5. Postoperative recurrent pattern and the lymph node metastatic stations of the thoracic esophageal squamous cell carcinoma
Chunyang LI ; Jing YU ; Jiuling SHEN ; Wen OUYANG ; Yu XU ; Junhong ZHANG ; Conghua XIE
Chinese Journal of Radiation Oncology 2019;28(9):673-676
Objective:
To investigate postoperative recurrent pattern of the thoracic esophageal squamous cell carcinoma (TESCC), aiming to provide a basis for the delineation of postoperative radiotherapy volume for TESCC.
Methods:
Clinical data of 66 TESCC patients who recurred after the radical esophagectomy in Zhongnan Hospital of Wuhan University from 2011 to 2017 were retrospectively analyzed. According to the AJCC 8th edition-defined classification of esophageal carcinoma, regional lymph node stations 1 to 8M were defined as the upper-middle mediastinum region (UMMR), and stations 8Lo, 9 and 15 were defined as the inferior mediastinum region (IMR), stations 16 to 20 were regarded as the upper abdominal lymph node region (UAR).
Results:
Among all 66 patients, 41 cases (62%) experienced loco-regional recurrence alone, 25 cases (38%) presented with distant metastasis alone. A total of 54 patients with 148 lymph node recurred after treatment. The highest risk region of lymph node recurrence was UMMR (118/148, 80%), after that, followed by UAR (24/148, 17%). With regard to 9 cases of UAR, 6 patients had lower TESCC, and 8 patients (89%) were graded as ≥ pathological stage Ⅲ.
Conclusions
The highest risk region of lymph node recurrence is UMMR in TESCC patients undergoing radical esophagectomy, which should be considered as the target volume in postoperative radiotherapy. For patients with lower TESCC ≥ pathological stage Ⅲ, UAR might be the target volume with cautions. Anastomosis and IMR are probably not the routine treatment volumes.
6.Research on the precision and stability of optical surface imaging technology in guiding radiotherapy positioning
Lu YANG ; Renming ZHONG ; Guangjun LI ; Jiuling SHEN ; Liqin LI ; Sen BAI
Chinese Journal of Radiation Oncology 2018;27(4):387-391
Objective To investigate the precision and stability of optical surface imaging (OSI)system Catalyst in guiding radiotherapy positioning.Methods A total of 52 patients with five different tumor sites who underwent cone-beam computed tomography (CBCT)-guided radiotherapy were recruited in this investigation.For the first treatment fraction,the setup error was recorded as C after online CBCT correction,and the surface images of patients taken by Catalyst were set as the reference images Cref.For the following treatment fraction,patients were pre-corrected according to the Catalyst Cref image with the acceptable errors within 2 mm/ 2,and the pre-corrected errors were recorded as C1.Then,after online CBCT correction,the setup errors were recorded as C.The errors between post-corrected Catalyst surface image and Cref image were recorded as C2.For each treatment fraction,the difference between Catalyst correction errors C1 and CBCT corrected errors C was recorded as d1,and the difference between the post-corrected Catalyst errors C2 and Cref image was recorded as d2.d3=d1-d2.The values of d1 and d3 in the 6 dimensions were analyzed using single sample t-test.The correlation between C-C1 and d1-d2 was statistically analyzed by Pearson correlation analysis.Results The mean value of d1 and d3 for 52 patients were within 2 mm/2 °.CBCT-C1 and d1-d2 were both significantly correlated (R =3,7,P=0.00,0.01).Conclusions OSI system yield high accuracy and stability in radiotherapy positioning,which is of certain significance in radiotherapy positioning for cancer patients.
7.The impact of electronic portal imaging device position error on 3D dose verification of volumetric modulated arc therapy
Dajiang WANG ; Sheng CHANG ; Jiuling SHEN ; Liqin LI ; Guangjun LI ; Sen BAI
Chinese Journal of Radiological Medicine and Protection 2017;37(4):259-263
Objective To analyze the impact of electronic portal imagingdevice (EPID) position error on three-dimensional dose verification of volumetric modulated arc therapy (VMAT).Metbods Five Suremark SL-20 lead points were fixed on Elekta tray,and EPID images were collected in 0-360° rotation,one image per 5°.The position error relative to the accelerator was analyzed via Matlab.Then the images position error was corrected according to the analysis,and the 3D dose was reconstructed with the corrected images.The dose distributions of double arcs,clockwise arc(arc 1),and counterclockwise arc (arc 2) of 16 nasopharyngeal carcinoma patients' VMAT plan were evaluated by γ analysis,and the results of before and after position error correction were compared.Results Compared to 0° gantry angle,the error of source to the image distance (SID) was maximum (1.20 cm) when the gantry angle was 180°.On account of the SID change,the maximum error along the up-down (y) direction in the iso-center planar was 2.28 mm and the left-right (x) direction error was within ± O.5 mm.The 3D γ analyses of 16 nasopharyngeal carcinoma in VMAT plans were obviously increased after the position error along y was corrected.The double arcs,arc1 and arc 2 were increased by (4.12 ±1.67) % (t =-9.86,P< 0.05),(3.47±1.64) % (t=-8.46,P< 0.05) and (5.08±1.30) % (t=-15.63,P< 0.05) in 5%/3 mm standard,respectively.However,in 3%/3 mm standard,γ value of the double arcs,arc 1 and arc2 were increased by (7.63 ±2.24) % (t =-13.63,P< 0.05),(6.03 ±2.07) % (t =-11.66,P< 0.05),(9.17 ±2.23) % (t =-16.41,P< 0.05),respectively.Since the EPID position error along x was corrected after y,the 3D γ analysis of reconstruction dose indicated that the average of the 5%/3 mm and 3%/3 mm γ value were increased by 0.23% and 0.24%,respectively.Conclusions EPID motion error along the gantry to table direction of the accelerator can't be ignored.When reconstruct dose based on EPID,a modification should be made for rebuilding more accurate patients' 3D dose distribution.
8.Implementation and development of independent check in radiotherapy
Jiuling SHEN ; Guangjun LI ; Liqin LI ; Fubo LIU ; Sen BAI
Chinese Journal of Radiation Oncology 2017;26(6):715-718
Independent check is one of the key measures of quality control (QC) in radiotherapy and is essential for the assurance of radiotherapy accuracy.In recent years,with the application of computer-aided system,the automaticity of independent check,as well as its accuracy and efficiency,increases.Meanwhile,QC has evolved from a device-centered to a process-centered program.Therefore,independent check has been increasingly systematic and specific.This review gives a brief summary of the implementation and development of independent check.
9.Research progress in electronic portal imaging device-based in vivo dosimetry verification
Liqin LI ; Guangjun LI ; Jiuling SHEN ; Sen BAI
Chinese Journal of Radiation Oncology 2017;26(7):833-837
In vivo dosimetry (IVD) is currently the most direct and effective means of quality assurance.The electronic portal imaging device (EPID) has been widely used for IVD verification owing to its favorable dosimetric properties.In recent years,an increasing number of EPID-based IVD studies have emerged around the world.The purpose of this paper is to give an overview of the present progress in EPID-based IVD studies,and to provide a reference for the subsequent application of EPID in IVD.
10.Progress in application of failure mode and effect analysis in the quality control of radiotherapy process
Jiuling SHEN ; guangjun LI ; sen BAI
Chinese Journal of Radiation Oncology 2017;26(11):1354-1358
With the rapid development of radiotherapy technology, traditional quality management will shift from a device-centric strategy to a process involving multiple people. In recent years,failure mode and effect analysis(FMEA)based on predictive risk assessment has gradually been applied in the quality management of radiotherapy process. The FMEA approach mainly includes four steps: process tree management,FMEA, error tree analysis, and the design of scheme for process quality management. The specific methods and results are different due to the specificity of radiotherapy process and the subjectivity of participants. Its reliability and feasibility have also been considered and verified. This article reviews the application of FMEA approach in some radiotherapy centers.

Result Analysis
Print
Save
E-mail